166 related articles for article (PubMed ID: 1591057)
1. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.
Boysen M; Lövdal O; Tausjö J; Winther F
Eur J Cancer; 1992; 28(2-3):426-30. PubMed ID: 1591057
[TBL] [Abstract][Full Text] [Related]
2. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer.
Flynn CJ; Khaouam N; Gardner S; Higgins K; Enepekides D; Balogh J; MacKenzie R; Singh S; Davidson J; Poon I
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):868-73. PubMed ID: 20650620
[TBL] [Abstract][Full Text] [Related]
3. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?
de Visscher AV; Manni JJ
Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):934-9. PubMed ID: 8074820
[TBL] [Abstract][Full Text] [Related]
4. Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma.
Zätterström U; Boysen M; Evensen JF
Anticancer Res; 2014 Nov; 34(11):6593-9. PubMed ID: 25368263
[TBL] [Abstract][Full Text] [Related]
5. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
Lester SE; Wight RG
Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
[TBL] [Abstract][Full Text] [Related]
6. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
7. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck.
Marchant FE; Lowry LD; Moffitt JJ; Sabbagh R
Am J Otolaryngol; 1993; 14(2):88-93. PubMed ID: 8484482
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
9. Correlation between subjective evaluation of symptoms and objective findings in early recurrent head and neck squamous cell carcinoma.
Nisa L; La Macchia R; Boujelbene N; Sandu K; Khanfir K; Giger R
JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):687-93. PubMed ID: 23788001
[TBL] [Abstract][Full Text] [Related]
10. The value of routine follow-up in patients treated for carcinoma of the vulva.
Oonk MH; de Hullu JA; Hollema H; Mourits MJ; Pras E; Wymenga AN; van der Zee AG
Cancer; 2003 Dec; 98(12):2624-9. PubMed ID: 14669281
[TBL] [Abstract][Full Text] [Related]
11. Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.
van de Weerd C; Geurts SME; Vercoulen RJMT; van Veggel IHF; Brands MT; Marres HAM; Hermens RPMG; van Tol-Geerdink JJ; Kaanders JHAM; Takes RP
Eur J Surg Oncol; 2024 Jan; 50(1):107304. PubMed ID: 38043360
[TBL] [Abstract][Full Text] [Related]
12. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
13. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Hong WK; Lippman SM; Itri LM; Karp DD; Lee JS; Byers RM; Schantz SP; Kramer AM; Lotan R; Peters LJ
N Engl J Med; 1990 Sep; 323(12):795-801. PubMed ID: 2202902
[TBL] [Abstract][Full Text] [Related]
14. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
[TBL] [Abstract][Full Text] [Related]
15. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
16. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck.
Boysen M; Natvig K; Winther FO; Tausjö J
J Otolaryngol; 1985 Aug; 14(4):211-4. PubMed ID: 4057330
[TBL] [Abstract][Full Text] [Related]
17. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
18. Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
Boysen ME; Zätterström UK; Evensen JF
Anticancer Res; 2016 Jun; 36(6):2849-54. PubMed ID: 27272796
[TBL] [Abstract][Full Text] [Related]
19. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.
Digonnet A; Hamoir M; Andry G; Haigentz M; Takes RP; Silver CE; Hartl DM; Strojan P; Rinaldo A; de Bree R; Dietz A; Grégoire V; Paleri V; Langendijk JA; Vander Poorten V; Hinni ML; Rodrigo JP; Suárez C; Mendenhall WM; Werner JA; Genden EM; Ferlito A
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1569-80. PubMed ID: 22972497
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
